Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC).

Katherine Sanchez; Shu-Ching Chang; Isaac Kim; Maritza Martel; Yaping Wu; William L Redmond; Zhaoyu Sun; Dottie Waddell; Deborah R Laxague; Brady Bernard; Monil Shah; Walter Urba; David B Page

Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC).

Katherine Sanchez, Shu-Ching Chang, Isaac Kim, Maritza Martel, Yaping Wu, William L Redmond, Zhaoyu Sun, Dottie Waddell, Deborah R Laxague, Brady Bernard, Monil Shah, Walter Urba, David B Page

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
State	Published - May 25 2020

Disciplines

Oncology

Access to Document

https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e12589?af=R

Cite this

Sanchez, K., Chang, S.-C., Kim, I., Martel, M., Wu, Y., Redmond, W. L., Sun, Z., Waddell, D., Laxague, D. R., Bernard, B., Shah, M., Urba, W., & Page, D. B. (2020). Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e12589?af=R

@article{9d4d082cd1a140b4accecc439a81eaf1,

title = "Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC).",

author = "Katherine Sanchez and Shu-Ching Chang and Isaac Kim and Maritza Martel and Yaping Wu and Redmond, {William L} and Zhaoyu Sun and Dottie Waddell and Laxague, {Deborah R} and Brady Bernard and Monil Shah and Walter Urba and Page, {David B}",

year = "2020",

month = may,

day = "25",

language = "American English",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

}

Sanchez, K, Chang, S-C, Kim, I, Martel, M, Wu, Y, Redmond, WL, Sun, Z, Waddell, D, Laxague, DR, Bernard, B, Shah, M, Urba, W & Page, DB 2020, 'Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC).', Journal of clinical oncology : official journal of the American Society of Clinical Oncology. <https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e12589?af=R>

Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC). / Sanchez, Katherine; Chang, Shu-Ching; Kim, Isaac et al.
In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25.05.2020.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC).

AU - Sanchez, Katherine

AU - Chang, Shu-Ching

AU - Kim, Isaac

AU - Martel, Maritza

AU - Wu, Yaping

AU - Redmond, William L

AU - Sun, Zhaoyu

AU - Waddell, Dottie

AU - Laxague, Deborah R

AU - Bernard, Brady

AU - Shah, Monil

AU - Urba, Walter

AU - Page, David B

PY - 2020/5/25

Y1 - 2020/5/25

UR - https://digitalcommons.psjhealth.org/publications/3760

UR - https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e12589?af=R

M3 - Article

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ER -

Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC).

Disciplines

Access to Document

Other files and links

Cite this